Literature DB >> 13513744

Demonstration of a circulating anticoagulant in plasma thromboplastin antecedent deficiency.

A M JOSEPHSON, R LISKER.   

Abstract

Keywords:  HEMOPHILIA/blood in

Mesh:

Substances:

Year:  1958        PMID: 13513744      PMCID: PMC293070          DOI: 10.1172/JCI103592

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  11 in total

1.  Plasma thromboplastin antecedent deficiency.

Authors:  B RAMOT; B ANGELOPOULOS; K SINGER
Journal:  AMA Arch Intern Med       Date:  1955-05

2.  Immunization of rabbits against human anti-hemophilic factor (AHF).

Authors:  M D RICHARDS; T H SPAET
Journal:  Blood       Date:  1956-05       Impact factor: 22.113

3.  The correction of a hemorrhagic diathesis in preparation for surgery; the correction of plasma thromboplastin antecedent deficiency.

Authors:  R LISKER; A M JOSEPHSON; G WERBIN; C M SHAPIRO; S ROZENGVAIG
Journal:  AMA Arch Intern Med       Date:  1957-09

4.  A laboratory study of the carrier state in classic hemophilia.

Authors:  A MARGOLIUS; O D RATNOFF
Journal:  J Clin Invest       Date:  1956-11       Impact factor: 14.808

5.  Classification of hemophiliacs with development of an anticoagulant.

Authors:  L J BERGNA; A PAVLOVSKY
Journal:  Acta Haematol       Date:  1956-10       Impact factor: 2.195

6.  Production of anti-human PTC and anti-human proconvertin in rabbits.

Authors:  P DIDISHEIM; J H LEWIS
Journal:  Proc Soc Exp Biol Med       Date:  1956-12

7.  An unusual circulating anticoagulant in systemic lupus erythematosus.

Authors:  B RAMOT; K SINGER
Journal:  Acta Haematol       Date:  1956-08       Impact factor: 2.195

8.  Properties of plasma thromboplastin antecedent (PTA) in relation to blood coagulation.

Authors:  R L ROSENTHAL
Journal:  J Lab Clin Med       Date:  1955-01

9.  The thromboplastin generation test.

Authors:  R BIGGS; A S DOUGLAS
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

10.  The coagulation mechanism, with specific reference to the interpretation of prothrombin time and a consideration of the prothrombin consumption time.

Authors:  A J QUICK
Journal:  Am J Clin Pathol       Date:  1949-11       Impact factor: 2.493

View more
  1 in total

1.  Acquired antibody to factor XI in a patient with congenital factor XI deficiency.

Authors:  D M Stern; H L Nossel; J Owen
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.